{"id":57381,"date":"2025-12-25T14:00:32","date_gmt":"2025-12-25T18:00:32","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/the-trump-market-a-rollercoaster-of-tweets-tariffs-and-unexpected-triumphs\/57381\/"},"modified":"2025-12-25T14:00:32","modified_gmt":"2025-12-25T18:00:32","slug":"the-trump-market-a-rollercoaster-of-tweets-tariffs-and-unexpected-triumphs","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/the-trump-market-a-rollercoaster-of-tweets-tariffs-and-unexpected-triumphs\/57381\/","title":{"rendered":"The Trump Market: A Rollercoaster of Tweets, Tariffs, and Unexpected Triumphs"},"content":{"rendered":"

Ah, the financial markets under the watchful, or perhaps, tweeting, eye of Donald J. Trump<\/a>. It’s a spectacle, truly. A high-stakes drama where policy pronouncements drop like bombshells, only to be followed by market gyrations that often defy conventional economic wisdom. One might expect chaos, and indeed, there are moments of sheer panic. Yet, somehow, the indices often find a way to shrug it off, leaving analysts scratching their heads and investors wondering if they should buy the dip or brace for impact. It’s less about fundamental analysis and more about reading the tea leaves of a late-night Truth Social post.<\/p>\n

The Art of the Deal… with Pharmaceutical Companies<\/h2>\n

Consider the recent saga of prescription drug pricing. President Trump<\/a>, ever the champion of the common consumer (and a good headline), announced a series of deals with no fewer than nine pharmaceutical giants, promising to slash drug prices. The Presidential Prayer Team, among others, dutifully reported on “President Trump Announces Lower Prescription Drug Pricing”. One might imagine pharmaceutical stocks plummeting in a fit of corporate despair. But, in a twist that would make M. Night Shyamalan proud, the opposite occurred. On December 19, 2025, shares of most involved drugmakers, including GILD<\/a> (Gilead Sciences), BMY<\/a> (Bristol Myers Squibb), GSK<\/a> (GSK<\/a>), MRK<\/a> (Merck), and AMGN<\/a> (Amgen), actually *rose* by 1% to 3%.<\/p>\n

This paradoxical market reaction wasn’t a sign of investor irrationality, but rather a testament to the market’s uncanny ability to sniff out the real story. As Bernstein analyst Courtney Breen so eloquently put it, these deals were largely an exercise in “delivering headlines and minimiz[ing] any step-change in company economics”. William Blair analyst Matt Phipps echoed this sentiment, describing them as “another round of pandering on carefully selected drugs” with “negligible effects on sales and profits”. Apparently, a three-year exemption from potential tariffs was a far more potent elixir for these companies than any supposed price cuts were poison. It seems the pharmaceutical industry knows a good photo op when it sees one, especially when it comes with a side of tariff relief. Meanwhile, health insurer stocks like CI<\/a> (Cigna) and UNH<\/a> (UnitedHealth Group) saw brief dips of about 1% after Trump’s comments about meeting with them to lower costs, only to recover with the speed of a well-insured patient after a minor ailment. The memory of pharma stocks slumping 2-3% back in May 2025 on earlier threats of price cuts seems almost quaint now.<\/p>\n

Building a “Golden Fleet” (and Shareholder Value)<\/h2>\n

Not content with merely tinkering with drug prices, President Trump also set his sights on the high seas, announcing ambitious plans for a new “Trump-class” battleship fleet, a “Golden Fleet” designed to make America’s adversaries (read: China) tremble. The vision includes 20 to 25 new vessels, with construction on the first two, including the USS Defiant, set to begin “almost immediately”. This, naturally, sent defense contractors into a flurry of activity\u2014the good kind of flurry.<\/p>\n

Huntington Ingalls Industries (HII<\/a>), a major shipbuilding stock, promptly hit a fresh record high of $360.20 on December 23, 2025, having already surged 5% the previous day on the news. Its shares rose another 4% in extended trading, proving that nothing says “investor confidence” quite like the promise of colossal, missile-heavy warships. Even South Korean shipbuilder Hanwha Ocean (042660<\/a>) saw its shares rocket by 12.5% in Seoul, as it was tapped to help construct these magnificent beasts. The broader defense sector, it should be noted, has been on a tear throughout 2025, with HII<\/a> alone adding a robust 87.1% since the year’s commencement. Analysts, ever the optimists when government contracts loom large, have assigned a “Moderate Buy” rating to HII<\/a>, recognizing the “aggressive industrial policy” as a significant tailwind. The only slight wrinkle in this otherwise smooth sailing? Trump’s musings about limiting defense contractors’ stock buybacks and dividends, and tying executive pay to performance. Because, apparently, making $50 million a year while not building fast enough is just un-American.<\/p>\n

The Venezuelan Oil “Quarantine”: A Barrel of Volatility<\/h2>\n

Geopolitics, too, remains a potent market mover. President Trump’s decision to order a “blockade” (later softened to a “quarantine” in a nod to historical euphemisms) of sanctioned oil tankers entering and leaving Venezuela certainly injected a dose of uncertainty into the energy markets. The aim, ostensibly, was to ratchet up pressure on the Maduro regime. The immediate effect? A predictable spike in oil prices. On December 18, 2025, U.S. West Texas Intermediate (WTI<\/a>) crude surged by 98 cents, or 1.7%, reaching $56.89 per barrel, while Brent crude climbed 92 cents, or 1.54%, to $60.60 per barrel. This sudden jump was particularly noteworthy as it followed a period where oil prices had languished at five-year lows.<\/p>\n

Analysts, ever keen to point out the obvious, noted the “unexpected escalation” and the resulting “supply disruption concerns”. ING analyst Warren Patterson highlighted “clear risks to the Venezuelan oil supply”. Of course, some experts remained skeptical about the long-term impact on global supplies. It’s almost as if the market has learned to expect a certain level of dramatic pronouncement, followed by a brief, sharp reaction, before settling back into its regularly scheduled programming of geopolitical hand-wringing. The “quarantine” might be a strong word, but for oil traders, it just meant another opportunity for a quick profit.<\/p>\n

China Tariffs: The Long Game of “Delay and Threaten”<\/h2>\n

Perhaps the most enduring theme of the Trump era has been the trade relationship with China. The latest installment involves semiconductors, with the administration concluding that China’s chip policies are “unreasonable”. However, in a move that can only be described as a masterclass in strategic ambiguity, new tariffs have been *delayed* until June 23, 2027. The current tariff rate? A perfectly benign 0%. The exact rate for 2027, naturally, will be announced closer to the date, keeping everyone on their toes.<\/p>\n

This “delay and threaten” strategy, following an “uneasy trade truce” in October, was met with a sigh of relief in the semiconductor sector. The decision to postpone tariffs removed a “near-term policy overhang,” particularly for companies like NVDA<\/a> (Nvidia) with extensive global supply chains. Equity markets, ever appreciative of a reprieve, viewed the delay as “modestly constructive” for the tech sector, especially for mega-cap technology stocks. Analysts suggested this was a tactical move to manage tensions, providing “breathing room” for U.S. industries reliant on Chinese legacy chips. Yet, the underlying message is clear: the threat remains, a Sword of Damocles hanging over the industry, ensuring that “policy uncertainty beyond 2026 will continue to cap valuation multiples for chipmakers with meaningful China exposure”. It’s a trade war on layaway, with the bill coming due in 2027.<\/p>\n

The Broader Market: A “Fantastic” Ride, Despite Everything<\/h2>\n

Despite the constant barrage of policy announcements, threats, and reversals, the U.S. stock market in December 2025 has, by many accounts, been “fantastic”. The S&P 500<\/a> (SPX<\/a>) climbed nearly 14% since Trump’s inauguration through early December, and by December 11, it had returned over 18% for the year, hitting a record high. The benchmark index added a robust 16% year to date. This resilience comes despite periods of significant volatility, such as the 5% plunge in the S&P 500 on April 3, 2025, triggered by Trump’s initial announcement of sweeping tariffs, which he later paused.<\/p>\n

Even the Federal Reserve found itself in an “abnormally divided” state regarding interest rates, largely due to the economic uncertainties stemming from Trump’s tariff policies. Meanwhile, on Truth Social, President Trump continued to tout a 4.3% GDP and “no inflation,” a narrative that, while perhaps comforting to some, often diverged from the broader economic data. It seems the market, much like a seasoned investor, has developed a thick skin, learning to filter the noise from the actual impact, and often finding opportunity in the very volatility that keeps everyone else guessing. The “Trump Market” isn’t boring, that’s for sure. It’s a testament to the market’s enduring, if sometimes bewildering, ability to thrive amidst a perpetual state of “will-he-or-won’t-he” policy drama.<\/p>\n

DISCLAIMER: <\/b> We read Trump’s posts so you don’t have to. This is comedy meets market data, not financial advice. Not political advice either – we just like charts and chaos.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"

Ah, the financial markets under the watchful, or perhaps, tweeting, eye of Donald J. Trump. It’s a spectacle, truly. A […]<\/p>\n","protected":false},"author":8,"featured_media":50312,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[4331],"tags":[],"class_list":["post-57381","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-trump-stock-market"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/57381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=57381"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/57381\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50312"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=57381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=57381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=57381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}